Alector, Inc.
Alector, Inc.（ALEC）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · ALEC · 截至 2025年9月30日
股东结构概览
157
机构持有人数
▲ 20 vs Q2
$221.31M
机构持仓总市值
▲ $122.59M vs Q2
111.03M
总流通股
freeFloat 70.68%
74.77M
13F 申报持股数
▲ 4.26M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
ALEC 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
FMR LLC biological products, (no diagnostic substances) | 15.18M | 15.13% | 15.13% | $44.94B | Nov 13, 2025 | ▲ 183.0K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 7.20M | 7.17% | 7.17% | $21.31B | Nov 12, 2025 | ▼ 775.6K |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 6.99M | 6.96% | 6.96% | $20.69B | Nov 14, 2025 | NEW |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 6.03M | 6.01% | 6.01% | $17.86B | Nov 7, 2025 | ▲ 47.0K |
MERCK & CO., INC. biological products, (no diagnostic substances) | 3.55M | 3.53% | 3.53% | $10.50B | Nov 12, 2025 | — held |
ACADIAN ASSET MANAGEMENT LLC biological products, (no diagnostic substances) | 2.37M | 2.36% | 2.36% | $7.02B | Nov 13, 2025 | ▲ 202.6K |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 2.19M | 2.18% | 2.18% | $6.47B | Nov 14, 2025 | ▼ 2.69M |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 1.86M | 1.85% | 1.85% | $5.51B | Nov 12, 2025 | ▼ 120.8K |
STATE STREET CORP biological products, (no diagnostic substances) | 1.73M | 1.73% | 1.73% | $5.13B | Nov 14, 2025 | ▲ 24.8K |
EVERSEPT PARTNERS, LP biological products, (no diagnostic substances) | 1.49M | 1.48% | 1.48% | $4.41B | Nov 14, 2025 | ▼ 497.3K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
25
增持
+4.89M 股3
新建仓
首次建仓16
减持
−5.72M 股0
清仓
完全退出净股数变化（前50家）
829.8K
+4.89M / −5.72M
净新增持仓人
+12
新建 3 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
ALEC 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
0
买入笔数
1
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
SCHELLER RICHARD H director | Jun 1, 2026 | Award | 10,833 | — | — | 106.2K | Form 4 ↗ |
Wong-Sarad Grace Principal Accounting Officer | Apr 16, 2026 | Sale | 1,820 | $2.65 | $4.8K | 104.6K | Form 4 ↗ |
Rosenthal Arnon Chief Executive Officer | Mar 13, 2026 | Award | 116,246 | — | — | 2.45M | Form 4 ↗ |
Berkley Neil Lindsay CFO & Chief Business Officer | Mar 15, 2026 | Award | 54,600 | — | — | 399.3K | Form 4 ↗ |
Wong-Sarad Grace Principal Accounting Officer | Mar 10, 2026 | Sale | 1,000 | $2.65 | $2.6K | 106.5K | Form 4 ↗ |
Wong-Sarad Grace Principal Accounting Officer | Mar 3, 2026 | Sale | 3,367 | $2.08 | $7.0K | 107.5K | Form 4 ↗ |
Wong-Sarad Grace Principal Accounting Officer | Mar 2, 2026 | Sale | 8,071 | $2.12 | $17.1K | 110.8K | Form 4 ↗ |
Rosenthal Arnon Chief Executive Officer | Mar 2, 2026 | Sale | 81,864 | $2.12 | $173.8K | 2.34M | Form 4 ↗ |
Berkley Neil Lindsay CFO & Chief Business Officer | Mar 2, 2026 | Sale | 29,649 | $2.12 | $63.0K | 344.7K | Form 4 ↗ |
Wong-Sarad Grace Principal Accounting Officer | Feb 26, 2026 | Sale | 4,079 | $2.50 | $10.2K | 118.9K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Alector, Inc.（ALEC）主要由机构投资者持有，机构持股比例约为 67.3%。公司内部人员持股约 29.32%，散户及公众持股约占剩余的 3.34%。
Alector, Inc. 最大机构股东为 FMR LLC，截至 September 30, 2025 持有约 15.18 million 股，占总流通股的 15.13%。
目前共有 157 家机构持有 ALEC 股票，合计持仓市值约 $221,307,345，数据来源为最新 SEC 13F 申报。
常见问题
ALEC ownershipAlector, Inc.（ALEC）主要由机构投资者持有，机构持股约 67.3%。最大股东为 FMR LLC，持股比例 15.13%。内部人员持股约 29.32%。数据来源 SEC Form 13F，截至 September 30, 2025。